Literature DB >> 15950657

A randomized trial of excision versus ablation for mild endometriosis.

Jeremy Wright1, Hany Lotfallah, Kevin Jones, David Lovell.   

Abstract

OBJECTIVE: To compare excisional and ablative treatment modalities for mild (revised American Fertility score 1-2) endometriosis in the management of chronic pelvic pain.
DESIGN: A randomized study of excision or ablation for mild endometriosis, participants and investigators alike blinded to the treatment modality at the follow-up visit.
SETTING: District general hospital with a specialist pelvic pain clinic in the United Kingdom. PATIENT(S): Women presenting with chronic pelvic pain. INTERVENTION(S): Participants were asked to complete a questionnaire detailing symptoms related to chronic pelvic pain and rating their pain on a ranked ordinal scale. Areas of pelvic tenderness were identified and similarly ranked. At laparoscopy they were randomly assigned to excision or ablation of any endometriotic lesions, and the questionnaire was repeated at 6 months. MAIN OUTCOME MEASURE(S): Changes in pain score on a ranked ordinal scale after surgical treatment for mild endometriosis. RESULT(S): Both treatment modalities produced good symptomatic relief and reduction of pelvic tenderness (67%). There was no difference in morbidity; one woman in each group became pregnant during the study period. Only two participants reported no relief or a worsening of symptoms or signs. CONCLUSION(S): This small study showed good symptom relief at 6 months from pelvic pain for the majority of participants irrespective of the treatment modality, but two participants did not improve or got worse. A high pain score before treatment was a predictor of appreciable improvement. Further work is needed to identify women in whom surgical intervention is likely to produce a good response.

Entities:  

Mesh:

Year:  2005        PMID: 15950657     DOI: 10.1016/j.fertnstert.2004.11.066

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

Review 1.  Endometriosis.

Authors:  Simone Ferrero; Valentino Remorgida; Pier Luigi Venturini
Journal:  BMJ Clin Evid       Date:  2010-08-13

Review 2.  Management of chronic pelvic pain.

Authors:  Ja Hyun Shin; Fred M Howard
Journal:  Curr Pain Headache Rep       Date:  2011-10

3.  Surgery and Endometriosis.

Authors:  Austin Zanelotti; Alan H Decherney
Journal:  Clin Obstet Gynecol       Date:  2017-09       Impact factor: 2.190

4.  Laparoscopic surgery for endometriosis.

Authors:  Celine Bafort; Yusuf Beebeejaun; Carla Tomassetti; Jan Bosteels; James Mn Duffy
Journal:  Cochrane Database Syst Rev       Date:  2020-10-23

5.  Optimal management of chronic cyclical pelvic pain: an evidence-based and pragmatic approach.

Authors:  Ha Ryun Won; Jason Abbott
Journal:  Int J Womens Health       Date:  2010-08-20

Review 6.  Endometriosis: pathogenesis and treatment.

Authors:  Paolo Vercellini; Paola Viganò; Edgardo Somigliana; Luigi Fedele
Journal:  Nat Rev Endocrinol       Date:  2013-12-24       Impact factor: 43.330

Review 7.  Endometriosis.

Authors:  Neil Johnson; Cynthia Farquhar
Journal:  BMJ Clin Evid       Date:  2007-03-01

8.  When and how should peritoneal endometriosis be operated on in order to improve fertility rates and symptoms? The experience and outcomes of nearly 100 cases.

Authors:  A M Dückelmann; E Taube; E Abesadze; V Chiantera; J Sehouli; S Mechsner
Journal:  Arch Gynecol Obstet       Date:  2021-02-03       Impact factor: 2.344

9.  A pilot feasibility multicenter study of patients after excision of endometriosis.

Authors:  Patrick Yeung; Frank Tu; Krisztina Bajzak; Georgine Lamvu; Olga Guzovsky; Rob Agnelli; Mary Peavey; Wendy Winer; Robert Albee; Ken Sinervo
Journal:  JSLS       Date:  2013 Jan-Mar       Impact factor: 2.172

10.  Endometriosis in adolescents is a hidden, progressive and severe disease that deserves attention, not just compassion.

Authors:  I Brosens; S Gordts; G Benagiano
Journal:  Hum Reprod       Date:  2013-06-05       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.